Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis

NCT03518502 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Metastasis

Interventions

PROCEDURE: transarterial chemoembolization (TACE)
DRUG: Sorafenib

Sponsor

Korea University

Collaborators

[object Object]